Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Deborah Schrag, M.D.

Title
Institution
Department
Address
Phone
Fax

Research
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. UM1CA233080 (SCHRAG, DEBORAH) Sep 20, 2018 - Jun 30, 2023
    NIH/NCI
    SIMPRO Research Center: Integration and Implementation of PROs for Symptom Management in Oncology Practice
    Role: Principal Investigator
  2. P20CA217231 (IRAZOLA, VILMA) Sep 15, 2017 - Aug 31, 2019
    NIH/NCI
    Building sustainable and innovative research in Cancer and Cardiovascular disease: Planning the design and development of the South American Center of Research Excellence to Counter NCDs (SACREN)
    Role: Co-Principal Investigator
  3. K05CA169384 (SCHRAG, DEBORAH) Aug 16, 2012 - Jul 31, 2017
    NIH/NCI
    Partnerships Between Medicaid, Tumor Registries & Cancer Control Researchers
    Role: Principal Investigator
  4. U54CA156732 (VISWANATH, KASISOMAYAJULA) Sep 27, 2010 - Aug 31, 2021
    NIH/NCI
    2/2 The University of Massachusetts, Boston - Dana-Farber/Harvard Cancer Center U54 Comprehensive Partnership for Cancer Disparities Research
    Role: Co-Principal Investigator
  5. R01CA131847 (SCHRAG, DEBORAH) Jul 31, 2008 - May 31, 2014
    NIH/NCI
    Cancer Care Delivery in Medicaid
    Role: Principal Investigator

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Ng K, Nimeiri HS, McCleary NJ, Abrams TA, Yurgelun MB, Cleary JM, Rubinson DA, Schrag D, Miksad R, Bullock AJ, Allen J, Zuckerman D, Chan E, Chan JA, Wolpin BM, Constantine M, Weckstein DJ, Faggen MA, Thomas CA, Kournioti C, Yuan C, Ganser C, Wilkinson B, Mackintosh C, Zheng H, Hollis BW, Meyerhardt JA, Fuchs CS. Effect of High-Dose vs Standard-Dose Vitamin D3 Supplementation on Progression-Free Survival Among Patients With Advanced or Metastatic Colorectal Cancer: The SUNSHINE Randomized Clinical Trial. JAMA. 2019 04 09; 321(14):1370-1379. PMID: 30964527.
    Citations:    
  2. Kehl KL, Lathan CS, Johnson BE, Schrag D. Race, Poverty, and Initial Implementation of Precision Medicine for Lung Cancer. J Natl Cancer Inst. 2019 Apr 01; 111(4):431-434. PMID: 30576459.
    Citations:    Fields:    
  3. Cleary JM, Horick NK, McCleary NJ, Abrams TA, Yurgelun MB, Azzoli CG, Rubinson DA, Brooks GA, Chan JA, Blaszkowsky LS, Clark JW, Goyal L, Meyerhardt JA, Ng K, Schrag D, Savarese DMF, Graham C, Fitzpatrick B, Gibb KA, Boucher Y, Duda DG, Jain RK, Fuchs CS, Enzinger PC. FOLFOX plus ziv-aflibercept or placebo in first-line metastatic esophagogastric adenocarcinoma: A double-blind, randomized, multicenter phase 2 trial. Cancer. 2019 Mar 26. PMID: 30913304.
    Citations:    
  4. Kehl KL, Yang S, Awad MM, Palmer N, Kohane IS, Schrag D. Pre-existing autoimmune disease and the risk of immune-related adverse events among patients receiving checkpoint inhibitors for cancer. Cancer Immunol Immunother. 2019 Jun; 68(6):917-926. PMID: 30877325.
    Citations:    
  5. Schrag D, Weiser M, Saltz L, Mamon H, Gollub M, Basch E, Venook A, Shi Q. Challenges and solutions in the design and execution of the PROSPECT Phase II/III neoadjuvant rectal cancer trial (NCCTG N1048/Alliance). Clin Trials. 2019 Apr; 16(2):165-175. PMID: 30688523.
    Citations:    Fields:    
  6. Schrag D, Basch E. Oncology in Transition: Changes, Challenges, and Opportunities. JAMA. 2018 12 04; 320(21):2203-2204. PMID: 30419140.
    Citations:    Fields:    
  7. Tramontano AC, Nipp R, Mercaldo ND, Kong CY, Schrag D, Hur C. Survival Disparities by Race and Ethnicity in Early Esophageal Cancer. Dig Dis Sci. 2018 11; 63(11):2880-2888. PMID: 30109578.
    Citations:    Fields:    
  8. Schoen MW, Basch E, Hudson LL, Chung AE, Mendoza TR, Mitchell SA, St Germain D, Baumgartner P, Sit L, Rogak LJ, Shouery M, Shalley E, Reeve BB, Fawzy MR, Bhavsar NA, Cleeland C, Schrag D, Dueck AC, Abernethy AP. Software for Administering the National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events: Usability Study. JMIR Hum Factors. 2018 Jul 16; 5(3):e10070. PMID: 30012546.
    Citations:    
  9. Snyder RA, Hu CY, Cuddy A, Francescatti AB, Schumacher JR, Van Loon K, You YN, Kozower BD, Greenberg CC, Schrag D, Venook A, McKellar D, Winchester DP, Chang GJ. Association Between Intensity of Posttreatment Surveillance Testing and Detection of Recurrence in Patients With Colorectal Cancer. JAMA. 2018 05 22; 319(20):2104-2115. PMID: 29800181.
    Citations: 1     Fields:    Translation:Humans
  10. Hassett MJ, Jiang W, Hughes ME, Edge S, Javid SH, Niland JC, Theriault R, Wong YN, Schrag D, Punglia RS. Treating Second Breast Events After Breast-Conserving Surgery for Ductal Carcinoma in Situ. J Natl Compr Canc Netw. 2018 04; 16(4):387-394. PMID: 29632058.
    Citations:    Fields:    
  11. Nipp R, Tramontano AC, Kong CY, Pandharipande P, Dowling EC, Schrag D, Hur C. Disparities in cancer outcomes across age, sex, and race/ethnicity among patients with pancreatic cancer. Cancer Med. 2018 02; 7(2):525-535. PMID: 29322643.
    Citations: 2     Fields:    
  12. Keating NL, Huskamp HA, Schrag D, McWilliams JM, McNeil BJ, Landon BE, Chernew ME, Normand ST. Diffusion of Bevacizumab Across Oncology Practices: An Observational Study. Med Care. 2018 01; 56(1):69-77. PMID: 29135615.
    Citations:    Fields:    Translation:Humans
  13. Reyngold M, Niland J, Ter Veer A, Bekaii-Saab T, Lai L, Meyer JE, Nurkin SJ, Schrag D, Skibber JM, Benson AB, Weiser MR, Crane CH, Goodman KA. Trends in intensity modulated radiation therapy use for locally advanced rectal cancer at National Comprehensive Cancer Network centers. Adv Radiat Oncol. 2018 Jan-Mar; 3(1):34-41. PMID: 29556578.
    Citations:    
  14. Chen AB, Li L, Cronin AM, Brooks GA, Kavanagh BD, Schrag D. Estimating Costs of Care Attributable to Cancer: Does the Choice of Comparison Group Matter? Health Serv Res. 2018 08; 53 Suppl 1:3227-3244. PMID: 28858372.
    Citations:    Fields:    
  15. Yao XI, Wang X, Speicher PJ, Hwang ES, Cheng P, Harpole DH, Berry MF, Schrag D, Pang HH. Reporting and Guidelines in Propensity Score Analysis: A Systematic Review of Cancer and Cancer Surgical Studies. J Natl Cancer Inst. 2017 08 01; 109(8). PMID: 28376195.
    Citations: 5     Fields:    Translation:Humans
  16. Basch E, Deal AM, Dueck AC, Scher HI, Kris MG, Hudis C, Schrag D. Overall Survival Results of a Trial Assessing Patient-Reported Outcomes for Symptom Monitoring During Routine Cancer Treatment. JAMA. 2017 07 11; 318(2):197-198. PMID: 28586821.
    Citations: 42     Fields:    Translation:Humans
  17. Venook AP, Niedzwiecki D, Lenz HJ, Innocenti F, Fruth B, Meyerhardt JA, Schrag D, Greene C, O'Neil BH, Atkins JN, Berry S, Polite BN, O'Reilly EM, Goldberg RM, Hochster HS, Schilsky RL, Bertagnolli MM, El-Khoueiry AB, Watson P, Benson AB, Mulkerin DL, Mayer RJ, Blanke C. Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild-Type Advanced or Metastatic Colorectal Cancer: A Randomized Clinical Trial. JAMA. 2017 06 20; 317(23):2392-2401. PMID: 28632865.
    Citations: 22     Fields:    Translation:Humans
  18. Pomerantz MM, Spisák S, Jia L, Cronin AM, Csabai I, Ledet E, Sartor AO, Rainville I, O'Connor EP, Herbert ZT, Szállási Z, Oh WK, Kantoff PW, Garber JE, Schrag D, Kibel AS, Freedman ML. The association between germline BRCA2 variants and sensitivity to platinum-based chemotherapy among men with metastatic prostate cancer. Cancer. 2017 Sep 15; 123(18):3532-3539. PMID: 28608931.
    Citations: 5     Fields:    Translation:Humans
  19. Kastrinos F, Uno H, Ukaegbu C, Alvero C, McFarland A, Yurgelun MB, Kulke MH, Schrag D, Meyerhardt JA, Fuchs CS, Mayer RJ, Ng K, Steyerberg EW, Syngal S. Development and Validation of the PREMM5 Model for Comprehensive Risk Assessment of Lynch Syndrome. J Clin Oncol. 2017 Jul 01; 35(19):2165-2172. PMID: 28489507.
    Citations: 6     Fields:    Translation:Humans
  20. Abrams TA, Meyer G, Meyerhardt JA, Wolpin BM, Schrag D, Fuchs CS. Patterns of Chemotherapy Use in a U.S.-Based Cohort of Patients with Metastatic Pancreatic Cancer. Oncologist. 2017 08; 22(8):925-933. PMID: 28476943.
    Citations: 2     Fields:    Translation:Humans
  21. Tramontano AC, Sheehan DF, Yeh JM, Kong CY, Dowling EC, Rubenstein JH, Abrams JA, Inadomi JM, Schrag D, Hur C. The Impact of a Prior Diagnosis of Barrett's Esophagus on Esophageal Adenocarcinoma Survival. Am J Gastroenterol. 2017 Aug; 112(8):1256-1264. PMID: 28374815.
    Citations: 5     Fields:    Translation:Humans
  22. Enzinger AC, Wind JK, Frank E, McCleary NJ, Porter L, Cushing H, Abbott C, Cronin C, Enzinger PC, Meropol NJ, Schrag D. A stakeholder-driven approach to improve the informed consent process for palliative chemotherapy. Patient Educ Couns. 2017 Aug; 100(8):1527-1536. PMID: 28359659.
    Citations: 2     Fields:    Translation:Humans
  23. Mendoza TR, Dueck AC, Bennett AV, Mitchell SA, Reeve BB, Atkinson TM, Li Y, Castro KM, Denicoff A, Rogak LJ, Piekarz RL, Cleeland CS, Sloan JA, Schrag D, Basch E. Evaluation of different recall periods for the US National Cancer Institute's PRO-CTCAE. Clin Trials. 2017 Jun; 14(3):255-263. PMID: 28545337.
    Citations: 4     Fields:    Translation:Humans
  24. Yeh JM, Tramontano AC, Hur C, Schrag D. Comparative effectiveness of adjuvant chemoradiotherapy after gastrectomy among older patients with gastric adenocarcinoma: a SEER-Medicare study. Gastric Cancer. 2017 Sep; 20(5):811-824. PMID: 28205057.
    Citations:    Fields:    Translation:Humans
  25. Yurgelun MB, Kulke MH, Fuchs CS, Allen BA, Uno H, Hornick JL, Ukaegbu CI, Brais LK, McNamara PG, Mayer RJ, Schrag D, Meyerhardt JA, Ng K, Kidd J, Singh N, Hartman AR, Wenstrup RJ, Syngal S. Cancer Susceptibility Gene Mutations in Individuals With Colorectal Cancer. J Clin Oncol. 2017 Apr 01; 35(10):1086-1095. PMID: 28135145.
    Citations: 15     Fields:    Translation:Humans
  26. Punglia RS, Cronin AM, Uno H, Stout NK, Ozanne EM, Greenberg CC, Frank ES, Schrag D. Association of Regional Intensity of Ductal Carcinoma In Situ Treatment With Likelihood of Breast Preservation. JAMA Oncol. 2017 Jan 01; 3(1):101-104. PMID: 27442038.
    Citations:    Fields:    Translation:Humans
  27. Abdel-Misih SR, Wei L, Benson AB, Cohen S, Lai L, Skibber J, Wilkinson N, Weiser M, Schrag D, Bekaii-Saab T. Neoadjuvant Therapy for Rectal Cancer Affects Lymph Node Yield and Status Without Clear Implications on Outcome: The Case for Eliminating a Metric and Using Preoperative Staging to Guide Therapy. J Natl Compr Canc Netw. 2016 12; 14(12):1528-1534. PMID: 27956537.
    Citations: 3     Fields:    Translation:Humans
  28. Arvold ND, Cefalu M, Wang Y, Zigler C, Schrag D, Dominici F. Comparative effectiveness of radiotherapy with vs. without temozolomide in older patients with glioblastoma. J Neurooncol. 2017 01; 131(2):301-311. PMID: 27770280.
    Citations: 2     Fields:    Translation:Humans
  29. Popescu I, Schrag D, Ang A, Wong M. Racial/Ethnic and Socioeconomic Differences in Colorectal and Breast Cancer Treatment Quality: The Role of Physician-level Variations in Care. Med Care. 2016 08; 54(8):780-8. PMID: 27326547.
    Citations: 4     Fields:    Translation:Humans
  30. Warren JL, Mariotto A, Melbert D, Schrag D, Doria-Rose P, Penson D, Yabroff KR. Sensitivity of Medicare Claims to Identify Cancer Recurrence in Elderly Colorectal and Breast Cancer Patients. Med Care. 2016 08; 54(8):e47-54. PMID: 24374419.
    Citations: 9     Fields:    Translation:Humans
  31. Halpern MT, Schrag D. Effects of state-level medicaid policies and patient characteristics on time to breast cancer surgery among medicaid beneficiaries. Breast Cancer Res Treat. 2016 08; 158(3):573-81. PMID: 27422241.
    Citations:    Fields:    Translation:Humans
  32. Jazic I, Schrag D, Sargent DJ, Haneuse S. Beyond Composite Endpoints Analysis: Semicompeting Risks as an Underutilized Framework for Cancer Research. J Natl Cancer Inst. 2016 12; 108(12). PMID: 27381741.
    Citations:    Fields:    Translation:Humans
  33. Schnipper LE, Davidson NE, Wollins DS, Blayney DW, Dicker AP, Ganz PA, Hoverman JR, Langdon R, Lyman GH, Meropol NJ, Mulvey T, Newcomer L, Peppercorn J, Polite B, Raghavan D, Rossi G, Saltz L, Schrag D, Smith TJ, Yu PP, Hudis CA, Vose JM, Schilsky RL. Updating the American Society of Clinical Oncology Value Framework: Revisions and Reflections in Response to Comments Received. J Clin Oncol. 2016 08 20; 34(24):2925-34. PMID: 27247218.
    Citations: 34     Fields:    Translation:Humans
  34. Schrag D. Optimizing Treatment for Locally Advanced Pancreas Cancer: Progress but No Precision. JAMA. 2016 May 03; 315(17):1837-8. PMID: 27139054.
    Citations: 4     Fields:    Translation:Humans
  35. Bennett AV, Dueck AC, Mitchell SA, Mendoza TR, Reeve BB, Atkinson TM, Castro KM, Denicoff A, Rogak LJ, Harness JK, Bearden JD, Bryant D, Siegel RD, Schrag D, Basch E. Mode equivalence and acceptability of tablet computer-, interactive voice response system-, and paper-based administration of the U.S. National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE). Health Qual Life Outcomes. 2016 Feb 19; 14:24. PMID: 26892667.
    Citations: 13     Fields:    Translation:HumansPHPublic Health
  36. Garcia-Aguilar J, Glynne-Jones R, Schrag D. Multimodal Rectal Cancer Treatment: In Some Cases, Less May Be More. Am Soc Clin Oncol Educ Book. 2016; 35:92-102. PMID: 27249690.
    Citations:    Fields:    Translation:Humans
  37. Mack JW, Chen K, Boscoe FP, Gesten FC, Roohan PJ, Schymura MJ, Schrag D. High Intensity of End-of-Life Care Among Adolescent and Young Adult Cancer Patients in the New York State Medicaid Program. Med Care. 2015 Dec; 53(12):1018-26. PMID: 26492211.
    Citations: 6     Fields:    Translation:Humans
  38. Brooks GA, Cronin AM, Uno H, Schrag D, Keating NL, Mack JW. Intensity of Medical Interventions between Diagnosis and Death in Patients with Advanced Lung and Colorectal Cancer: A CanCORS Analysis. J Palliat Med. 2016 Jan; 19(1):42-50. PMID: 26600474.
    Citations: 2     Fields:    Translation:Humans
  39. Hassett MJ, Schymura MJ, Chen K, Boscoe FP, Gesten FC, Schrag D. Variation in breast cancer care quality in New York and California based on race/ethnicity and Medicaid enrollment. Cancer. 2016 Feb 01; 122(3):420-31. PMID: 26536043.
    Citations: 7     Fields:    Translation:Humans
  40. Dueck AC, Mendoza TR, Mitchell SA, Reeve BB, Castro KM, Rogak LJ, Atkinson TM, Bennett AV, Denicoff AM, O'Mara AM, Li Y, Clauser SB, Bryant DM, Bearden JD, Gillis TA, Harness JK, Siegel RD, Paul DB, Cleeland CS, Schrag D, Sloan JA, Abernethy AP, Bruner DW, Minasian LM, Basch E. Validity and Reliability of the US National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE). JAMA Oncol. 2015 Nov; 1(8):1051-9. PMID: 26270597.
    Citations: 56     Fields:    Translation:HumansPHPublic Health
  41. Schnipper LE, Davidson NE, Wollins DS, Tyne C, Blayney DW, Blum D, Dicker AP, Ganz PA, Hoverman JR, Langdon R, Lyman GH, Meropol NJ, Mulvey T, Newcomer L, Peppercorn J, Polite B, Raghavan D, Rossi G, Saltz L, Schrag D, Smith TJ, Yu PP, Hudis CA, Schilsky RL. American Society of Clinical Oncology Statement: A Conceptual Framework to Assess the Value of Cancer Treatment Options. J Clin Oncol. 2015 Aug 10; 33(23):2563-77. PMID: 26101248.
    Citations: 95     Fields:    Translation:Humans
  42. Hiatt RA, Tai CG, Blayney DW, Deapen D, Hogarth M, Kizer KW, Lipscomb J, Malin J, Phillips SK, Santa J, Schrag D. Leveraging state cancer registries to measure and improve the quality of cancer care: a potential strategy for California and beyond. J Natl Cancer Inst. 2015 Mar 11; 107(5). PMID: 25766400.
    Citations: 3     Fields:    Translation:Humans
  43. Tramontano AC, Schrag DL, Malin JK, Miller MC, Weeks JC, Swan JS, McMahon PM. Catalog and comparison of societal preferences (utilities) for lung cancer health states: results from the Cancer Care Outcomes Research and Surveillance (CanCORS) study. Med Decis Making. 2015 04; 35(3):371-87. PMID: 25670839.
    Citations: 2     Fields:    Translation:Humans
  44. Weiser MR, Zhang Z, Schrag D. Locally advanced rectal cancer: time for precision therapeutics. Am Soc Clin Oncol Educ Book. 2015; e192-6. PMID: 25993172.
    Citations: 2     Fields:    Translation:Humans
  45. Yeo H, Niland J, Milne D, ter Veer A, Bekaii-Saab T, Farma JM, Lai L, Skibber JM, Small W, Wilkinson N, Schrag D, Weiser MR. Incidence of minimally invasive colorectal cancer surgery at National Comprehensive Cancer Network centers. J Natl Cancer Inst. 2015 Jan; 107(1):362. PMID: 25527640.
    Citations: 14     Fields:    Translation:Humans
  46. Chen AB, Li L, Cronin A, Schrag D. Comparative effectiveness of intensity-modulated versus 3D conformal radiation therapy among medicare patients with stage III lung cancer. J Thorac Oncol. 2014 Dec; 9(12):1788-95. PMID: 25226428.
    Citations: 9     Fields:    Translation:Humans
  47. García-Albéniz X, Logan RW, Schrag D, Hernán MA. Evaluation of the duplication of staging CT scans for localized colon cancer in a Medicare population. Med Care. 2014 Nov; 52(11):963-8. PMID: 25226545.
    Citations: 1     Fields:    Translation:Humans
  48. Uno H, Cronin AM, Wadleigh M, Schrag D, Abel GA. Derivation and validation of the SEER-Medicare myelodysplastic syndromes risk score (SMMRS). Leuk Res. 2014 Dec; 38(12):1420-4. PMID: 25443886.
    Citations: 2     Fields:    Translation:Humans
  49. Basch E, Reeve BB, Mitchell SA, Clauser SB, Minasian LM, Dueck AC, Mendoza TR, Hay J, Atkinson TM, Abernethy AP, Bruner DW, Cleeland CS, Sloan JA, Chilukuri R, Baumgartner P, Denicoff A, St Germain D, O'Mara AM, Chen A, Kelaghan J, Bennett AV, Sit L, Rogak L, Barz A, Paul DB, Schrag D. Development of the National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE). J Natl Cancer Inst. 2014 Sep; 106(9). PMID: 25265940.
    Citations: 83     Fields:    Translation:Humans
  50. Kehl KL, Arora NK, Schrag D, Ayanian JZ, Clauser SB, Klabunde CN, Kahn KL, Fletcher RH, Keating NL. Discussions about clinical trials among patients with newly diagnosed lung and colorectal cancer. J Natl Cancer Inst. 2014 Oct; 106(10). PMID: 25217775.
    Citations: 8     Fields:    Translation:Humans
  51. Tejani MA, ter Veer A, Milne D, Ottesen R, Bekaii-Saab T, Benson AB, Schrag D, Shibata S, Skibber J, Weiser M, Wilkinson N, Cohen SJ. Systemic therapy for advanced appendiceal adenocarcinoma: an analysis from the NCCN Oncology Outcomes Database for colorectal cancer. J Natl Compr Canc Netw. 2014 Aug; 12(8):1123-30. PMID: 25099444.
    Citations: 8     Fields:    Translation:Humans
  52. Chawla N, Yabroff KR, Mariotto A, McNeel TS, Schrag D, Warren JL. Limited validity of diagnosis codes in Medicare claims for identifying cancer metastases and inferring stage. Ann Epidemiol. 2014 Sep; 24(9):666-72, 672.e1-2. PMID: 25066409.
    Citations: 8     Fields:    Translation:Humans
  53. Weeks JC, Uno H, Taback N, Ting G, Cronin A, D'Amico TA, Friedberg JW, Schrag D. Interinstitutional variation in management decisions for treatment of 4 common types of cancer: A multi-institutional cohort study. Ann Intern Med. 2014 Jul 01; 161(1):20-30. PMID: 24979447.
    Citations: 5     Fields:    Translation:Humans
  54. Wong AC, Stock S, Schrag D, Kahn KL, Salz T, Charlton ME, Rogers SO, Goodman KA, Keating NL. Physicians' beliefs about the benefits and risks of adjuvant therapies for stage II and stage III colorectal cancer. J Oncol Pract. 2014 Sep; 10(5):e360-7. PMID: 24986112.
    Citations: 2     Fields:    Translation:Humans
  55. Greenberg CC, Habel LA, Hughes ME, Nekhlyudov L, Achacoso N, Acton L, Schrag D, Jiang W, Edge S, Weeks JC, Punglia RS. Characterization and treatment of local recurrence following breast conservation for ductal carcinoma in situ. Ann Surg Oncol. 2014 Nov; 21(12):3766-73. PMID: 24859938.
    Citations: 1     Fields:    Translation:Humans
  56. Wolpin BM, Rubinson DA, Wang X, Chan JA, Cleary JM, Enzinger PC, Fuchs CS, McCleary NJ, Meyerhardt JA, Ng K, Schrag D, Sikora AL, Spicer BA, Killion L, Mamon H, Kimmelman AC. Phase II and pharmacodynamic study of autophagy inhibition using hydroxychloroquine in patients with metastatic pancreatic adenocarcinoma. Oncologist. 2014 Jun; 19(6):637-8. PMID: 24821822.
    Citations: 56     Fields:    Translation:HumansAnimalsCellsCTClinical Trials
  57. Bestvina CM, Zullig LL, Rushing C, Chino F, Samsa GP, Altomare I, Tulsky J, Ubel P, Schrag D, Nicolla J, Abernethy AP, Peppercorn J, Zafar SY. Patient-oncologist cost communication, financial distress, and medication adherence. J Oncol Pract. 2014 May; 10(3):162-7. PMID: 24839274.
    Citations: 23     Fields:    Translation:Humans
  58. Arvold ND, Wang Y, Zigler C, Schrag D, Dominici F. Hospitalization burden and survival among older glioblastoma patients. Neuro Oncol. 2014 Nov; 16(11):1530-40. PMID: 24778086.
    Citations: 8     Fields:    Translation:Humans
  59. Dodgion CM, Neville BA, Lipsitz SR, Schrag D, Breen E, Zinner MJ, Greenberg CC. Hospital variation in sphincter preservation for elderly rectal cancer patients. J Surg Res. 2014 Sep; 191(1):161-8. PMID: 24750983.
    Citations: 2     Fields:    Translation:Humans
  60. Reyngold M, Niland J, ter Veer A, Milne D, Bekaii-Saab T, Cohen SJ, Lai L, Schrag D, Skibber JM, Small W, Weiser M, Wilkinson N, Goodman KA. Neoadjuvant radiotherapy use in locally advanced rectal cancer at NCCN member institutions. J Natl Compr Canc Netw. 2014 Feb; 12(2):235-43. PMID: 24586085.
    Citations: 4     Fields:    Translation:Humans
  61. Abrams TA, Meyer G, Schrag D, Meyerhardt JA, Moloney J, Fuchs CS. Chemotherapy usage patterns in a US-wide cohort of patients with metastatic colorectal cancer. J Natl Cancer Inst. 2014 Feb; 106(2):djt371. PMID: 24511107.
    Citations: 11     Fields:    Translation:Humans
  62. Brooks GA, Abrams TA, Meyerhardt JA, Enzinger PC, Sommer K, Dalby CK, Uno H, Jacobson JO, Fuchs CS, Schrag D. Identification of potentially avoidable hospitalizations in patients with GI cancer. J Clin Oncol. 2014 Feb 20; 32(6):496-503. PMID: 24419123.
    Citations: 18     Fields:    Translation:Humans
  63. Schrag D, Weiser MR, Goodman KA, Gonen M, Hollywood E, Cercek A, Reidy-Lagunes DL, Gollub MJ, Shia J, Guillem JG, Temple LK, Paty PB, Saltz LB. Neoadjuvant chemotherapy without routine use of radiation therapy for patients with locally advanced rectal cancer: a pilot trial. J Clin Oncol. 2014 Feb 20; 32(6):513-8. PMID: 24419115.
    Citations: 70     Fields:    Translation:HumansCTClinical Trials
  64. Wang Y, Schrag D, Brooks GA, Dominici F. National trends in pancreatic cancer outcomes and pattern of care among Medicare beneficiaries, 2000 through 2010. Cancer. 2014 Apr 01; 120(7):1050-8. PMID: 24382787.
    Citations:    Fields:    Translation:Humans
  65. Meyerhardt JA, Mangu PB, Flynn PJ, Korde L, Loprinzi CL, Minsky BD, Petrelli NJ, Ryan K, Schrag DH, Wong SL, Benson AB. Follow-up care, surveillance protocol, and secondary prevention measures for survivors of colorectal cancer: American Society of Clinical Oncology clinical practice guideline endorsement. J Clin Oncol. 2013 Dec 10; 31(35):4465-70. PMID: 24220554.
    Citations: 41     Fields:    Translation:HumansPHPublic Health
  66. Rutter CM, Johnson EA, Feuer EJ, Knudsen AB, Kuntz KM, Schrag D. Secular trends in colon and rectal cancer relative survival. J Natl Cancer Inst. 2013 Dec 04; 105(23):1806-13. PMID: 24174654.
    Citations: 21     Fields:    Translation:Humans
  67. Shih YC, Ganz PA, Aberle D, Abernethy A, Bekelman J, Brawley O, Goodwin JS, Hu JC, Schrag D, Temel JS, Schnipper L. Delivering high-quality and affordable care throughout the cancer care continuum. J Clin Oncol. 2013 Nov 10; 31(32):4151-7. PMID: 24127450.
    Citations: 15     Fields:    Translation:Humans
  68. Martin MY, Fouad MN, Oster RA, Schrag D, Urmie J, Sanders S, Pisu M. What do cancer patients worry about when making decisions about treatment? Variation across racial/ethnic groups. Support Care Cancer. 2014 Jan; 22(1):233-44. PMID: 24037412.
    Citations: 7     Fields:    Translation:Humans
  69. Chawla N, Yabroff KR, Mariotto A, McNeel T, Schrag D, Warren J. PS1-39: Diagnosis Codes for Cancer Metastasis on Medicare Claims Have Limited Accuracy and Completeness. Clin Med Res. 2013 Sep; 11(3):131. PMID: 24085881.
    Citations:    
  70. Schrag D. Evolving role of neoadjuvant therapy in rectal cancer. Curr Treat Options Oncol. 2013 Sep; 14(3):350-64. PMID: 23828092.
    Citations: 7     Fields:    Translation:Humans
  71. Neuman HB, Weiss JM, Schrag D, Ronk K, Havlena J, LoConte NK, Smith MA, Greenberg CC. Patient demographic and tumor characteristics influencing oncologist follow-up frequency in older breast cancer survivors. Ann Surg Oncol. 2013 Dec; 20(13):4128-36. PMID: 23943027.
    Citations: 6     Fields:    Translation:Humans
  72. Elkin EB, Atoria CL, Leoce N, Bach PB, Schrag D. Changes in the availability of screening mammography, 2000-2010. Cancer. 2013 Nov 01; 119(21):3847-53. PMID: 23943323.
    Citations: 5     Fields:    Translation:HumansPHPublic Health
  73. Chen AB, Schrag D. Reply to F. Fiorica et al and D. Vordermark. J Clin Oncol. 2013 Jul 20; 31(21):2759-60. PMID: 24040666.
    Citations:    Fields:    Translation:Humans
  74. Chen AB, Cronin A, Weeks JC, Chrischilles EA, Malin J, Hayman JA, Schrag D. Expectations about the effectiveness of radiation therapy among patients with incurable lung cancer. J Clin Oncol. 2013 Jul 20; 31(21):2730-5. PMID: 23775958.
    Citations: 17     Fields:    Translation:Humans
  75. Mack JW, Chen K, Boscoe FP, Gesten FC, Roohan PJ, Weeks JC, Schymura MJ, Schrag D. Underuse of hospice care by Medicaid-insured patients with stage IV lung cancer in New York and California. J Clin Oncol. 2013 Jul 10; 31(20):2569-79. PMID: 23733768.
    Citations: 14     Fields:    Translation:Humans
  76. Judson TJ, Bennett AV, Rogak LJ, Sit L, Barz A, Kris MG, Hudis CA, Scher HI, Sabattini P, Schrag D, Basch E. Feasibility of long-term patient self-reporting of toxicities from home via the Internet during routine chemotherapy. J Clin Oncol. 2013 Jul 10; 31(20):2580-5. PMID: 23733753.
    Citations: 25     Fields:    Translation:Humans
  77. Soeteman DI, Stout NK, Ozanne EM, Greenberg C, Hassett MJ, Schrag D, Punglia RS. Modeling the effectiveness of initial management strategies for ductal carcinoma in situ. J Natl Cancer Inst. 2013 Jun 05; 105(11):774-81. PMID: 23644480.
    Citations: 4     Fields:    Translation:Humans
  78. Wolpin BM, Ng K, Zhu AX, Abrams T, Enzinger PC, McCleary NJ, Schrag D, Kwak EL, Allen JN, Bhargava P, Chan JA, Goessling W, Blaszkowsky LS, Supko JG, Elliot M, Sato K, Regan E, Meyerhardt JA, Fuchs CS. Multicenter phase II study of tivozanib (AV-951) and everolimus (RAD001) for patients with refractory, metastatic colorectal cancer. Oncologist. 2013; 18(4):377-8. PMID: 23580238.
    Citations: 10     Fields:    Translation:HumansCTClinical Trials
  79. Zhu J, Sharma DB, Chen AB, Johnson BE, Weeks JC, Schrag D. Comparative effectiveness of three platinum-doublet chemotherapy regimens in elderly patients with advanced non-small cell lung cancer. Cancer. 2013 Jun 01; 119(11):2048-60. PMID: 23564469.
    Citations: 3     Fields:    Translation:Humans
  80. Brooks GA, Li L, Sharma DB, Weeks JC, Hassett MJ, Yabroff KR, Schrag D. Regional variation in spending and survival for older adults with advanced cancer. J Natl Cancer Inst. 2013 May 01; 105(9):634-42. PMID: 23482657.
    Citations: 20     Fields:    Translation:Humans
  81. Elkin EB, Paige Nobles J, Pinheiro LC, Atoria CL, Schrag D. Changes in access to screening mammography, 2008-2011. Cancer Causes Control. 2013 May; 24(5):1057-9. PMID: 23468282.
    Citations: 1     Fields:    Translation:HumansPHPublic Health
  82. Greenberg CC, Wind JK, Chang GJ, Chen RC, Schrag D. Stakeholder engagement for comparative effectiveness research in cancer care: experience of the DEcIDE Cancer Consortium. J Comp Eff Res. 2013 Mar; 2(2):117-25. PMID: 24236554.
    Citations: 2     Fields:    Translation:Humans
  83. Zafar SY, Peppercorn JM, Schrag D, Taylor DH, Goetzinger AM, Zhong X, Abernethy AP. The financial toxicity of cancer treatment: a pilot study assessing out-of-pocket expenses and the insured cancer patient's experience. Oncologist. 2013; 18(4):381-90. PMID: 23442307.
    Citations: 100     Fields:    Translation:Humans
  84. Weeks JC, Mack JW, Schrag D. Talking with patients about dying. N Engl J Med. 2013 01 31; 368(5):480-1. PMID: 23363507.
    Citations: 2     Fields:    Translation:Humans
  85. Chen AB, Cronin A, Weeks JC, Chrischilles EA, Malin J, Hayman JA, Schrag D. Palliative radiation therapy practice in patients with metastatic non-small-cell lung cancer: a Cancer Care Outcomes Research and Surveillance Consortium (CanCORS) Study. J Clin Oncol. 2013 Feb 10; 31(5):558-64. PMID: 23295799.
    Citations: 16     Fields:    Translation:Humans
  86. McCleary NJ, Wigler D, Berry D, Sato K, Abrams T, Chan J, Enzinger P, Ng K, Wolpin B, Schrag D, Fuchs CS, Hurria A, Meyerhardt JA. Feasibility of computer-based self-administered cancer-specific geriatric assessment in older patients with gastrointestinal malignancy. Oncologist. 2013; 18(1):64-72. PMID: 23287880.
    Citations: 13     Fields:    Translation:Humans
  87. Dodgion CM, Neville BA, Lipsitz SR, Hu YY, Schrag D, Breen E, Greenberg CC. Do older Americans undergo stoma reversal following low anterior resection for rectal cancer? J Surg Res. 2013 Jul; 183(1):238-45. PMID: 23298948.
    Citations: 3     Fields:    Translation:Humans
  88. Elena JW, Travis LB, Simonds NI, Ambrosone CB, Ballard-Barbash R, Bhatia S, Cerhan JR, Hartge P, Heist RS, Kushi LH, Lash TL, Morton LM, Onel K, Pierce JP, Robison LL, Rowland JH, Schrag D, Sellers TA, Seminara D, Shu XO, Thomas NE, Ulrich CM, Freedman AN. Leveraging epidemiology and clinical studies of cancer outcomes: recommendations and opportunities for translational research. J Natl Cancer Inst. 2013 Jan 16; 105(2):85-94. PMID: 23197494.
    Citations: 17     Fields:    Translation:Humans
  89. Sinclair AH, Schymura MJ, Boscoe FP, Yung RL, Chen K, Roohan P, Tai E, Schrag D. Measuring colorectal cancer care quality for the publicly insured in New York State. Cancer Med. 2012 Dec; 1(3):363-71. PMID: 23342286.
    Citations: 4     Fields:    Translation:Humans
  90. Khrizman P, Niland JC, ter Veer A, Milne D, Bullard Dunn K, Carson WE, Engstrom PF, Shibata S, Skibber JM, Weiser MR, Schrag D, Benson AB. Postoperative adjuvant chemotherapy use in patients with stage II/III rectal cancer treated with neoadjuvant therapy: a national comprehensive cancer network analysis. J Clin Oncol. 2013 Jan 01; 31(1):30-8. PMID: 23169502.
    Citations: 30     Fields:    Translation:Humans
  91. Abel GA, Chen K, Taback N, Hassett MJ, Schrag D, Weeks JC. Impact of oncology-related direct-to-consumer advertising: association with appropriate and inappropriate prescriptions. Cancer. 2013 Mar 01; 119(5):1065-72. PMID: 23132702.
    Citations: 5     Fields:    Translation:Humans
  92. Knudsen AB, Hur C, Gazelle GS, Schrag D, McFarland EG, Kuntz KM. Rescreening of persons with a negative colonoscopy result: results from a microsimulation model. Ann Intern Med. 2012 Nov 06; 157(9):611-20. PMID: 23128861.
    Citations: 5     Fields:    Translation:HumansPHPublic Health
  93. Weeks JC, Catalano PJ, Cronin A, Finkelman MD, Mack JW, Keating NL, Schrag D. Patients' expectations about effects of chemotherapy for advanced cancer. N Engl J Med. 2012 Oct 25; 367(17):1616-25. PMID: 23094723.
    Citations: 178     Fields:    Translation:Humans
  94. Morikawa T, Tanaka N, Kuchiba A, Nosho K, Yamauchi M, Hornick JL, Swanson RS, Chan AT, Meyerhardt JA, Huttenhower C, Schrag D, Fuchs CS, Ogino S. Predictors of lymph node count in colorectal cancer resections: data from US nationwide prospective cohort studies. Arch Surg. 2012 Aug; 147(8):715-23. PMID: 22508672.
    Citations: 13     Fields:    Translation:HumansCells
  95. Yung RL, Hassett MJ, Chen K, Gesten FC, Roohan PJ, Boscoe FP, Sinclair AH, Schymura MJ, Schrag D. Initiation of adjuvant hormone therapy by Medicaid insured women with nonmetastatic breast cancer. J Natl Cancer Inst. 2012 Jul 18; 104(14):1102-5. PMID: 22773822.
    Citations: 11     Fields:    Translation:Humans
  96. Meyerhardt JA, Ancukiewicz M, Abrams TA, Schrag D, Enzinger PC, Chan JA, Kulke MH, Wolpin BM, Goldstein M, Blaszkowsky L, Zhu AX, Elliott M, Regan E, Jain RK, Duda DG. Phase I study of cetuximab, irinotecan, and vandetanib (ZD6474) as therapy for patients with previously treated metastastic colorectal cancer. PLoS One. 2012; 7(6):e38231. PMID: 22701615.
    Citations: 20     Fields:    Translation:HumansCTClinical Trials
  97. Sanoff HK, Carpenter WR, Stürmer T, Goldberg RM, Martin CF, Fine JP, McCleary NJ, Meyerhardt JA, Niland J, Kahn KL, Schymura MJ, Schrag D. Effect of adjuvant chemotherapy on survival of patients with stage III colon cancer diagnosed after age 75 years. J Clin Oncol. 2012 Jul 20; 30(21):2624-34. PMID: 22665536.
    Citations: 49     Fields:    Translation:Humans
  98. Feuer EJ, Lee M, Mariotto AB, Cronin KA, Scoppa S, Penson DF, Hachey M, Cynkin L, Carter GA, Campbell D, Percy-Laurry A, Zou Z, Schrag D, Hankey BF. The Cancer Survival Query System: making survival estimates from the Surveillance, Epidemiology, and End Results program more timely and relevant for recently diagnosed patients. Cancer. 2012 Nov 15; 118(22):5652-62. PMID: 22569947.
    Citations: 11     Fields:    Translation:Humans
  99. Zhu J, Sharma DB, Gray SW, Chen AB, Weeks JC, Schrag D. Carboplatin and paclitaxel with vs without bevacizumab in older patients with advanced non-small cell lung cancer. JAMA. 2012 Apr 18; 307(15):1593-601. PMID: 22511687.
    Citations: 33     Fields:    Translation:Humans
  100. Delate T, Witt DM, Ritzwoller D, Weeks JC, Kushi L, Hornbrook MC, Aiello Bowles EJ, Schrag D. Outpatient use of low molecular weight heparin monotherapy for first-line treatment of venous thromboembolism in advanced cancer. Oncologist. 2012; 17(3):419-27. PMID: 22334451.
    Citations: 7     Fields:    Translation:Humans
  101. Sanoff HK, Carpenter WR, Freburger J, Li L, Chen K, Zullig LL, Goldberg RM, Schymura MJ, Schrag D. Comparison of adverse events during 5-fluorouracil versus 5-fluorouracil/oxaliplatin adjuvant chemotherapy for stage III colon cancer: a population-based analysis. Cancer. 2012 Sep 01; 118(17):4309-20. PMID: 22294436.
    Citations: 20     Fields:    Translation:HumansPHPublic Health
  102. Sanoff HK, Carpenter WR, Martin CF, Sargent DJ, Meyerhardt JA, Stürmer T, Fine JP, Weeks J, Niland J, Kahn KL, Schymura MJ, Schrag D. Comparative effectiveness of oxaliplatin vs non-oxaliplatin-containing adjuvant chemotherapy for stage III colon cancer. J Natl Cancer Inst. 2012 Feb 08; 104(3):211-27. PMID: 22266473.
    Citations: 25     Fields:    Translation:Humans
  103. Meyerhardt JA, Li L, Sanoff HK, Carpenter W, Schrag D. Effectiveness of bevacizumab with first-line combination chemotherapy for Medicare patients with stage IV colorectal cancer. J Clin Oncol. 2012 Feb 20; 30(6):608-15. PMID: 22253466.
    Citations: 30     Fields:    Translation:Humans
  104. Romanus D, Kindler HL, Archer L, Basch E, Niedzwiecki D, Weeks J, Schrag D. Does health-related quality of life improve for advanced pancreatic cancer patients who respond to gemcitabine? Analysis of a randomized phase III trial of the cancer and leukemia group B (CALGB 80303). J Pain Symptom Manage. 2012 Feb; 43(2):205-17. PMID: 22104618.
    Citations: 16     Fields:    Translation:HumansCTClinical Trials
  105. Weiser MR, Gönen M, Chou JF, Kattan MW, Schrag D. Predicting survival after curative colectomy for cancer: individualizing colon cancer staging. J Clin Oncol. 2011 Dec 20; 29(36):4796-802. PMID: 22084366.
    Citations: 30     Fields:    Translation:Humans
  106. Elkin EB, Snow JG, Leoce NM, Atoria CL, Schrag D. Mammography capacity and appointment wait times: barriers to breast cancer screening. Cancer Causes Control. 2012 Jan; 23(1):45-50. PMID: 22037904.
    Citations: 6     Fields:    Translation:Humans
  107. Atkinson TM, Li Y, Coffey CW, Sit L, Shaw M, Lavene D, Bennett AV, Fruscione M, Rogak L, Hay J, Gönen M, Schrag D, Basch E. Reliability of adverse symptom event reporting by clinicians. Qual Life Res. 2012 Sep; 21(7):1159-64. PMID: 21984468.
    Citations: 33     Fields:    Translation:Humans
  108. Zafar SY, Malin JL, Grambow SC, Abbott DH, Schrag D, Kolimaga JT, Zullig LL, Weeks JC, Fouad MN, Ayanian JZ, Wallace R, Kahn KL, Ganz PA, Catalano P, West DW, Provenzale D. Early dissemination of bevacizumab for advanced colorectal cancer: a prospective cohort study. BMC Cancer. 2011 Aug 16; 11:354. PMID: 21846341.
    Citations: 4     Fields:    Translation:Humans
  109. Burstein HJ, Mangu PB, Somerfield MR, Schrag D, Samson D, Holt L, Zelman D, Ajani JA. American Society of Clinical Oncology clinical practice guideline update on the use of chemotherapy sensitivity and resistance assays. J Clin Oncol. 2011 Aug 20; 29(24):3328-30. PMID: 21788567.
    Citations: 35     Fields:    Translation:Humans
  110. Abrams TA, Brightly R, Mao J, Kirkner G, Meyerhardt JA, Schrag D, Fuchs CS. Patterns of adjuvant chemotherapy use in a population-based cohort of patients with resected stage II or III colon cancer. J Clin Oncol. 2011 Aug 20; 29(24):3255-62. PMID: 21768462.
    Citations: 13     Fields:    Translation:Humans
  111. Greenberg CC, Lipsitz SR, Neville B, In H, Hevelone N, Porter SA, Weeks C, Jha AK, Gawande AA, Schrag D, Weeks JC. Receipt of appropriate surgical care for Medicare beneficiaries with cancer. Arch Surg. 2011 Oct; 146(10):1128-34. PMID: 21690439.
    Citations: 16     Fields:    Translation:Humans
  112. Sher DJ, Neville BA, Chen AB, Schrag D. Predictors of IMRT and conformal radiotherapy use in head and neck squamous cell carcinoma: a SEER-Medicare analysis. Int J Radiat Oncol Biol Phys. 2011 Nov 15; 81(4):e197-206. PMID: 21596483.
    Citations: 9     Fields:    Translation:Humans
  113. Chen AB, Neville BA, Sher DJ, Chen K, Schrag D. Survival outcomes after radiation therapy for stage III non-small-cell lung cancer after adoption of computed tomography-based simulation. J Clin Oncol. 2011 Jun 10; 29(17):2305-11. PMID: 21537034.
    Citations: 10     Fields:    Translation:Humans
  114. Zhu AX, Abrams TA, Miksad R, Blaszkowsky LS, Meyerhardt JA, Zheng H, Muzikansky A, Clark JW, Kwak EL, Schrag D, Jors KR, Fuchs CS, Iafrate AJ, Borger DR, Ryan DP. Phase 1/2 study of everolimus in advanced hepatocellular carcinoma. Cancer. 2011 Nov 15; 117(22):5094-102. PMID: 21538343.
    Citations: 65     Fields:    Translation:HumansCTClinical Trials
  115. Martin MY, Pisu M, Oster RA, Urmie JM, Schrag D, Huskamp HA, Lee J, Kiefe CI, Fouad MN. Racial variation in willingness to trade financial resources for life-prolonging cancer treatment. Cancer. 2011 Aug 01; 117(15):3476-84. PMID: 21523759.
    Citations: 6     Fields:    Translation:Humans
  116. Bruner DW, Hanisch LJ, Reeve BB, Trotti AM, Schrag D, Sit L, Mendoza TR, Minasian L, O'Mara A, Denicoff AM, Rowland JH, Montello M, Geoghegan C, Abernethy AP, Clauser SB, Castro K, Mitchell SA, Burke L, Trentacosti AM, Basch EM. Stakeholder perspectives on implementing the National Cancer Institute's patient-reported outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE). Transl Behav Med. 2011 Mar; 1(1):110-22. PMID: 24073038.
    Citations: 14     Fields:    
  117. Yung RL, Chen K, Abel GA, Gesten FC, Roohan PJ, Boscoe FP, Sinclair AH, Schymura MJ, Schrag D. Cancer disparities in the context of Medicaid insurance: a comparison of survival for acute myeloid leukemia and Hodgkin's lymphoma by Medicaid enrollment. Oncologist. 2011; 16(8):1082-91. PMID: 21873583.
    Citations: 4     Fields:    Translation:Humans
  118. Boscoe FP, Schrag D, Chen K, Roohan PJ, Schymura MJ. Building capacity to assess cancer care in the Medicaid population in New York State. Health Serv Res. 2011 Jun; 46(3):805-20. PMID: 21158856.
    Citations: 14     Fields:    Translation:Humans
  119. Sima CS, Panageas KS, Schrag D. Cancer screening among patients with advanced cancer. JAMA. 2010 Oct 13; 304(14):1584-91. PMID: 20940384.
    Citations: 28     Fields:    Translation:HumansPHPublic Health
  120. Kindler HL, Niedzwiecki D, Hollis D, Sutherland S, Schrag D, Hurwitz H, Innocenti F, Mulcahy MF, O'Reilly E, Wozniak TF, Picus J, Bhargava P, Mayer RJ, Schilsky RL, Goldberg RM. Gemcitabine plus bevacizumab compared with gemcitabine plus placebo in patients with advanced pancreatic cancer: phase III trial of the Cancer and Leukemia Group B (CALGB 80303). J Clin Oncol. 2010 Aug 01; 28(22):3617-22. PMID: 20606091.
    Citations: 255     Fields:    Translation:HumansCTClinical Trials
  121. Chou JF, Row D, Gonen M, Liu YH, Schrag D, Weiser MR. Clinical and pathologic factors that predict lymph node yield from surgical specimens in colorectal cancer: a population-based study. Cancer. 2010 Jun 01; 116(11):2560-70. PMID: 20499400.
    Citations: 30     Fields:    Translation:Humans
  122. Ng K, Schrag D. Microsatellite instability and adjuvant fluorouracil chemotherapy: a mismatch? J Clin Oncol. 2010 Jul 10; 28(20):3207-10. PMID: 20498398.
    Citations: 15     Fields:    Translation:Humans
  123. Elkin EB, Ishill NM, Snow JG, Panageas KS, Bach PB, Liberman L, Wang F, Schrag D. Geographic access and the use of screening mammography. Med Care. 2010 Apr; 48(4):349-56. PMID: 20195174.
    Citations: 30     Fields:    Translation:HumansPHPublic Health
  124. Kahn KL, Adams JL, Weeks JC, Chrischilles EA, Schrag D, Ayanian JZ, Kiefe CI, Ganz PA, Bhoopalam N, Potosky AL, Harrington DP, Fletcher RH. Adjuvant chemotherapy use and adverse events among older patients with stage III colon cancer. JAMA. 2010 Mar 17; 303(11):1037-45. PMID: 20233821.
    Citations: 46     Fields:    Translation:Humans
  125. Jang TL, Bekelman JE, Liu Y, Bach PB, Basch EM, Elkin EB, Zelefsky MJ, Scardino PT, Begg CB, Schrag D. Physician visits prior to treatment for clinically localized prostate cancer. Arch Intern Med. 2010 Mar 08; 170(5):440-50. PMID: 20212180.
    Citations: 43     Fields:    Translation:Humans
  126. Sima CS, Panageas KS, Heller G, Schrag D. Analytical strategies for characterizing chemotherapy diffusion with patient-level population-based data. Appl Health Econ Health Policy. 2010; 8(1):37-51. PMID: 20038192.
    Citations: 1     Fields:    Translation:Humans
  127. Basch E, Jia X, Heller G, Barz A, Sit L, Fruscione M, Appawu M, Iasonos A, Atkinson T, Goldfarb S, Culkin A, Kris MG, Schrag D. Adverse symptom event reporting by patients vs clinicians: relationships with clinical outcomes. J Natl Cancer Inst. 2009 Dec 02; 101(23):1624-32. PMID: 19920223.
    Citations: 102     Fields:    Translation:Humans
  128. Gönen M, Schrag D, Weiser MR. Nodal staging score: a tool to assess adequate staging of node-negative colon cancer. J Clin Oncol. 2009 Dec 20; 27(36):6166-71. PMID: 19901106.
    Citations: 17     Fields:    Translation:Humans
  129. Wong SL, Mangu PB, Choti MA, Crocenzi TS, Dodd GD, Dorfman GS, Eng C, Fong Y, Giusti AF, Lu D, Marsland TA, Michelson R, Poston GJ, Schrag D, Seidenfeld J, Benson AB. American Society of Clinical Oncology 2009 clinical evidence review on radiofrequency ablation of hepatic metastases from colorectal cancer. J Clin Oncol. 2010 Jan 20; 28(3):493-508. PMID: 19841322.
    Citations: 101     Fields:    Translation:Humans
  130. Romanus D, Weiser MR, Skibber JM, Ter Veer A, Niland JC, Wilson JL, Rajput A, Wong YN, Benson AB, Shibata S, Schrag D. Concordance with NCCN Colorectal Cancer Guidelines and ASCO/NCCN Quality Measures: an NCCN institutional analysis. J Natl Compr Canc Netw. 2009 Sep; 7(8):895-904. PMID: 19755049.
    Citations: 17     Fields:    Translation:Humans
  131. Greenberg CC, Ashley SW, Schrag D. Centralization of cancer surgery: what does it mean for surgical training? J Clin Oncol. 2009 Oct 01; 27(28):4637-9. PMID: 19720900.
    Citations: 1     Fields:    Translation:Humans
  132. Yabroff KR, Schrag D. Challenges and opportunities for use of cost-effectiveness analysis. J Natl Cancer Inst. 2009 Sep 02; 101(17):1161-3. PMID: 19666852.
    Citations: 3     Fields:    Translation:Humans
  133. Temple LK, Romanus D, Niland J, Veer AT, Weiser MR, Skibber J, Wilson J, Rajput A, Benson A, Wong YN, Schrag D. Factors associated with sphincter-preserving surgery for rectal cancer at national comprehensive cancer network centers. Ann Surg. 2009 Aug; 250(2):260-7. PMID: 19638922.
    Citations: 12     Fields:    Translation:Humans
  134. Meropol NJ, Schrag D, Smith TJ, Mulvey TM, Langdon RM, Blum D, Ubel PA, Schnipper LE. American Society of Clinical Oncology guidance statement: the cost of cancer care. J Clin Oncol. 2009 Aug 10; 27(23):3868-74. PMID: 19581533.
    Citations: 120     Fields:    Translation:Humans
  135. Yabroff KR, Warren JL, Banthin J, Schrag D, Mariotto A, Lawrence W, Meekins A, Topor M, Brown ML. Comparison of approaches for estimating prevalence costs of care for cancer patients: what is the impact of data source? Med Care. 2009 Jul; 47(7 Suppl 1):S64-9. PMID: 19536016.
    Citations: 28     Fields:    Translation:Humans
  136. Yabroff KR, Warren JL, Schrag D, Mariotto A, Meekins A, Topor M, Brown ML. Comparison of approaches for estimating incidence costs of care for colorectal cancer patients. Med Care. 2009 Jul; 47(7 Suppl 1):S56-63. PMID: 19536010.
    Citations: 26     Fields:    Translation:Humans
  137. Pham HH, Landon BE, Reschovsky JD, Wu B, Schrag D. Rapidity and modality of imaging for acute low back pain in elderly patients. Arch Intern Med. 2009 May 25; 169(10):972-81. PMID: 19468091.
    Citations: 12     Fields:    Translation:Humans
  138. Ku GY, O'Reilly EM, Saltz LB, Schrag D, Maki RG, Kelsen DP, Ilson DH. Phase I study of weekly cisplatin, bolus fluorouracil and escalating doses of irinotecan in advanced solid tumors. Cancer Invest. 2009 May; 27(4):402-6. PMID: 19219674.
    Citations:    Fields:    Translation:HumansCTClinical Trials
  139. Phelps AC, Maciejewski PK, Nilsson M, Balboni TA, Wright AA, Paulk ME, Trice E, Schrag D, Peteet JR, Block SD, Prigerson HG. Religious coping and use of intensive life-prolonging care near death in patients with advanced cancer. JAMA. 2009 Mar 18; 301(11):1140-7. PMID: 19293414.
    Citations: 93     Fields:    Translation:Humans
  140. Schrag D. Evaluating the impact of organizational changes in health care delivery: challenges in study design. J Clin Oncol. 2009 Apr 10; 27(11):1744-5. PMID: 19273700.
    Citations: 1     Fields:    Translation:Humans
  141. Wideroff L, Phillips KA, Randhawa G, Ambs A, Armstrong K, Bennett CL, Brown ML, Donaldson MS, Follen M, Goldie SJ, Hiatt RA, Khoury MJ, Lewis G, McLeod HL, Piper M, Powell I, Schrag D, Schulman KA, Scott J. A health services research agenda for cellular, molecular and genomic technologies in cancer care. Public Health Genomics. 2009; 12(4):233-44. PMID: 19367091.
    Citations: 7     Fields:    Translation:Humans
  142. Pham HH, O'Malley AS, Bach PB, Saiontz-Martinez C, Schrag D. Primary care physicians' links to other physicians through Medicare patients: the scope of care coordination. Ann Intern Med. 2009 Feb 17; 150(4):236-42. PMID: 19221375.
    Citations: 50     Fields:    Translation:Humans
  143. Schrag D, Virnig BA, Warren JL. Linking tumor registry and Medicaid claims to evaluate cancer care delivery. Health Care Financ Rev. 2009; 30(4):61-73. PMID: 19719033.
    Citations: 6     Fields:    Translation:Humans
  144. Tew WP, Radovich D, O'Reilly E, Schwartz G, Schrag D, Saltz LB, Kelsen DP, Kepler S, Ilson DH. Phase I trial of weekly cisplatin, irinotecan and paclitaxel in patients with advanced gastrointestinal cancer. Invest New Drugs. 2009 Aug; 27(4):366-73. PMID: 18956138.
    Citations: 1     Fields:    Translation:HumansCTClinical Trials
  145. Desch CE, McNiff KK, Schneider EC, Schrag D, McClure J, Lepisto E, Donaldson MS, Kahn KL, Weeks JC, Ko CY, Stewart AK, Edge SB. American Society of Clinical Oncology/National Comprehensive Cancer Network Quality Measures. J Clin Oncol. 2008 Jul 20; 26(21):3631-7. PMID: 18640941.
    Citations: 58     Fields:    Translation:Humans
  146. Elkin EB, Ishill N, Riley GF, Bach PB, Gonen M, Begg CB, Schrag D. Disenrollment from Medicare managed care among beneficiaries with and without a cancer diagnosis. J Natl Cancer Inst. 2008 Jul 16; 100(14):1013-21. PMID: 18612131.
    Citations: 1     Fields:    Translation:Humans
  147. Quah HM, Chou JF, Gonen M, Shia J, Schrag D, Saltz LB, Goodman KA, Minsky BD, Wong WD, Weiser MR. Pathologic stage is most prognostic of disease-free survival in locally advanced rectal cancer patients after preoperative chemoradiation. Cancer. 2008 Jul 01; 113(1):57-64. PMID: 18442099.
    Citations: 56     Fields:    Translation:Humans
  148. Schrag D. Enhancing cancer registry data to promote rational health system design. J Natl Cancer Inst. 2008 Mar 19; 100(6):378-9. PMID: 18334703.
    Citations: 1     Fields:    Translation:Humans
  149. Iasonos A, Schrag D, Raj GV, Panageas KS. How to build and interpret a nomogram for cancer prognosis. J Clin Oncol. 2008 Mar 10; 26(8):1364-70. PMID: 18323559.
    Citations: 168     Fields:    Translation:Humans
  150. Quah HM, Chou JF, Gonen M, Shia J, Schrag D, Landmann RG, Guillem JG, Paty PB, Temple LK, Wong WD, Weiser MR. Identification of patients with high-risk stage II colon cancer for adjuvant therapy. Dis Colon Rectum. 2008 May; 51(5):503-7. PMID: 18322753.
    Citations: 47     Fields:    Translation:Humans
  151. Weiser MR, Landmann RG, Kattan MW, Gonen M, Shia J, Chou J, Paty PB, Guillem JG, Temple LK, Schrag D, Saltz LB, Wong WD. Individualized prediction of colon cancer recurrence using a nomogram. J Clin Oncol. 2008 Jan 20; 26(3):380-5. PMID: 18202413.
    Citations: 48     Fields:    Translation:Humans
  152. Vickers AJ, Bianco FJ, Gonen M, Cronin AM, Eastham JA, Schrag D, Klein EA, Reuther AM, Kattan MW, Pontes JE, Scardino PT. Effects of pathologic stage on the learning curve for radical prostatectomy: evidence that recurrence in organ-confined cancer is largely related to inadequate surgical technique. Eur Urol. 2008 May; 53(5):960-6. PMID: 18207316.
    Citations: 25     Fields:    Translation:Humans
  153. Roohipour R, Patil S, Goodman KA, Minsky BD, Wong WD, Guillem JG, Paty PB, Weiser MR, Neuman HB, Shia J, Schrag D, Temple LK. Squamous-cell carcinoma of the anal canal: predictors of treatment outcome. Dis Colon Rectum. 2008 Feb; 51(2):147-53. PMID: 18180997.
    Citations: 21     Fields:    Translation:Humans
  154. Basch E, Iasonos A, Barz A, Culkin A, Kris MG, Artz D, Fearn P, Speakman J, Farquhar R, Scher HI, McCabe M, Schrag D. Long-term toxicity monitoring via electronic patient-reported outcomes in patients receiving chemotherapy. J Clin Oncol. 2007 Dec 01; 25(34):5374-80. PMID: 18048818.
    Citations: 56     Fields:    Translation:Humans
  155. Elkin EB, Kim SH, Casper ES, Kissane DW, Schrag D. Desire for information and involvement in treatment decisions: elderly cancer patients' preferences and their physicians' perceptions. J Clin Oncol. 2007 Nov 20; 25(33):5275-80. PMID: 18024875.
    Citations: 63     Fields:    Translation:Humans
  156. Nahas CS, Shia J, Joseph R, Schrag D, Minsky BD, Weiser MR, Guillem JG, Paty PB, Klimstra DS, Tang LH, Wong WD, Temple LK. Squamous-cell carcinoma of the rectum: a rare but curable tumor. Dis Colon Rectum. 2007 Sep; 50(9):1393-400. PMID: 17661147.
    Citations: 22     Fields:    Translation:Humans
  157. Bekelman JE, Zelefsky MJ, Jang TL, Basch EM, Schrag D. Variation in adherence to external beam radiotherapy quality measures among elderly men with localized prostate cancer. Int J Radiat Oncol Biol Phys. 2007 Dec 01; 69(5):1456-66. PMID: 17689880.
    Citations: 7     Fields:    Translation:Humans
  158. Vickers AJ, Bianco FJ, Serio AM, Eastham JA, Schrag D, Klein EA, Reuther AM, Kattan MW, Pontes JE, Scardino PT. The surgical learning curve for prostate cancer control after radical prostatectomy. J Natl Cancer Inst. 2007 Aug 01; 99(15):1171-7. PMID: 17652279.
    Citations: 89     Fields:    Translation:Humans
  159. O'Malley AS, Pham HH, Schrag D, Wu B, Bach PB. Potentially avoidable hospitalizations for COPD and pneumonia: the role of physician and practice characteristics. Med Care. 2007 Jun; 45(6):562-70. PMID: 17515784.
    Citations: 15     Fields:    Translation:Humans
  160. Klabunde CN, Legler JM, Warren JL, Baldwin LM, Schrag D. A refined comorbidity measurement algorithm for claims-based studies of breast, prostate, colorectal, and lung cancer patients. Ann Epidemiol. 2007 Aug; 17(8):584-90. PMID: 17531502.
    Citations: 145     Fields:    Translation:Humans
  161. Panageas KS, Schrag D, Russell Localio A, Venkatraman ES, Begg CB. Properties of analysis methods that account for clustering in volume-outcome studies when the primary predictor is cluster size. Stat Med. 2007 Apr 30; 26(9):2017-35. PMID: 17016864.
    Citations: 19     Fields:    Translation:Humans
  162. Panageas KS, Ben-Porat L, Dickler MN, Chapman PB, Schrag D. When you look matters: the effect of assessment schedule on progression-free survival. J Natl Cancer Inst. 2007 Mar 21; 99(6):428-32. PMID: 17374832.
    Citations: 47     Fields:    Translation:HumansPHPublic Health
  163. Pham HH, Schrag D, O'Malley AS, Wu B, Bach PB. Care patterns in Medicare and their implications for pay for performance. N Engl J Med. 2007 Mar 15; 356(11):1130-9. PMID: 17360991.
    Citations: 130     Fields:    Translation:Humans
  164. Basch E, Artz D, Iasonos A, Speakman J, Shannon K, Lin K, Pun C, Yong H, Fearn P, Barz A, Scher HI, McCabe M, Schrag D. Evaluation of an online platform for cancer patient self-reporting of chemotherapy toxicities. J Am Med Inform Assoc. 2007 May-Jun; 14(3):264-8. PMID: 17329732.
    Citations: 33     Fields:    Translation:Humans
  165. Neuman HB, Schrag D, Cabral C, Weiser MR, Paty PB, Guillem JG, Minsky BD, Wong WD, Temple LK. Can differences in bowel function after surgery for rectal cancer be identified by the European Organization for Research and Treatment of Cancer quality of life instrument? Ann Surg Oncol. 2007 May; 14(5):1727-34. PMID: 17265117.
    Citations: 9     Fields:    Translation:Humans
  166. Schrag D, Hanger M. Medical oncologists' views on communicating with patients about chemotherapy costs: a pilot survey. J Clin Oncol. 2007 Jan 10; 25(2):233-7. PMID: 17210946.
    Citations: 44     Fields:    Translation:Humans
  167. Ballas LK, Elkin EB, Schrag D, Minsky BD, Bach PB. Radiation therapy facilities in the United States. Int J Radiat Oncol Biol Phys. 2006 Nov 15; 66(4):1204-11. PMID: 17145535.
    Citations: 13     Fields:    
  168. Basch E, Iasonos A, McDonough T, Barz A, Culkin A, Kris MG, Scher HI, Schrag D. Patient versus clinician symptom reporting using the National Cancer Institute Common Terminology Criteria for Adverse Events: results of a questionnaire-based study. Lancet Oncol. 2006 Nov; 7(11):903-9. PMID: 17081915.
    Citations: 105     Fields:    Translation:Humans
  169. Vogelaar I, van Ballegooijen M, Schrag D, Boer R, Winawer SJ, Habbema JD, Zauber AG. How much can current interventions reduce colorectal cancer mortality in the U.S.? Mortality projections for scenarios of risk-factor modification, screening, and treatment. Cancer. 2006 Oct 01; 107(7):1624-33. PMID: 16933324.
    Citations: 67     Fields:    Translation:HumansPHPublic Health
  170. Bekelman JE, Rosenzweig KE, Bach PB, Schrag D. Trends in the use of postoperative radiotherapy for resected non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2006 Oct 01; 66(2):492-9. PMID: 16814952.
    Citations: 10     Fields:    Translation:Humans
  171. Elkin EB, Hurria A, Mitra N, Schrag D, Panageas KS. Adjuvant chemotherapy and survival in older women with hormone receptor-negative breast cancer: assessing outcome in a population-based, observational cohort. J Clin Oncol. 2006 Jun 20; 24(18):2757-64. PMID: 16782916.
    Citations: 43     Fields:    Translation:Humans
  172. Paskett ED, Schrag D, Kornblith A, Lamont EB, Weeks JC, Marshall JR, Shapiro C, Holland J. Cancer and leukemia group B cancer control and health outcomes committee: origins and accomplishments. Clin Cancer Res. 2006 Jun 01; 12(11 Pt 2):3601s-5s. PMID: 16740792.
    Citations: 1     Fields:    Translation:Humans
  173. Schrag D, Xu F, Hanger M, Elkin E, Bickell NA, Bach PB. Fragmentation of care for frequently hospitalized urban residents. Med Care. 2006 Jun; 44(6):560-7. PMID: 16708005.
    Citations: 15     Fields:    Translation:Humans
  174. Indurkhya A, Mitra N, Schrag D. Using propensity scores to estimate the cost-effectiveness of medical therapies. Stat Med. 2006 May 15; 25(9):1561-76. PMID: 16158412.
    Citations: 9     Fields:    Translation:Humans
  175. Bickell NA, Wang JJ, Oluwole S, Schrag D, Godfrey H, Hiotis K, Mendez J, Guth AA. Missed opportunities: racial disparities in adjuvant breast cancer treatment. J Clin Oncol. 2006 Mar 20; 24(9):1357-62. PMID: 16549830.
    Citations: 122     Fields:    Translation:Humans
  176. Schrag D, Earle C, Xu F, Panageas KS, Yabroff KR, Bristow RE, Trimble EL, Warren JL. Associations between hospital and surgeon procedure volumes and patient outcomes after ovarian cancer resection. J Natl Cancer Inst. 2006 Feb 01; 98(3):163-71. PMID: 16449676.
    Citations: 26     Fields:    Translation:Humans
  177. Earle CC, Schrag D, Neville BA, Yabroff KR, Topor M, Fahey A, Trimble EL, Bodurka DC, Bristow RE, Carney M, Warren JL. Effect of surgeon specialty on processes of care and outcomes for ovarian cancer patients. J Natl Cancer Inst. 2006 Feb 01; 98(3):172-80. PMID: 16449677.
    Citations: 69     Fields:    Translation:Humans
  178. Chiao EY, Krown SE, Stier EA, Schrag D. A population-based analysis of temporal trends in the incidence of squamous anal canal cancer in relation to the HIV epidemic. J Acquir Immune Defic Syndr. 2005 Dec 01; 40(4):451-5. PMID: 16280701.
    Citations: 38     Fields:    Translation:Humans
  179. Jeong SY, Chessin DB, Schrag D, Riedel E, Wong WD, Guillem JG. Re: Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging. J Natl Cancer Inst. 2005 Nov 16; 97(22):1705-6; author reply 1706-7. PMID: 16288127.
    Citations: 6     Fields:    Translation:Humans
  180. Hillner BE, Schrag D, Sargent DJ, Fuchs CS, Goldberg RM. Cost-effectiveness projections of oxaliplatin and infusional fluorouracil versus irinotecan and bolus fluorouracil in first-line therapy for metastatic colorectal carcinoma. Cancer. 2005 Nov 01; 104(9):1871-84. PMID: 16177989.
    Citations: 14     Fields:    Translation:Humans
  181. Edwards BK, Brown ML, Wingo PA, Howe HL, Ward E, Ries LA, Schrag D, Jamison PM, Jemal A, Wu XC, Friedman C, Harlan L, Warren J, Anderson RN, Pickle LW. Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment. J Natl Cancer Inst. 2005 Oct 05; 97(19):1407-27. PMID: 16204691.
    Citations: 275     Fields:    Translation:HumansPHPublic Health
  182. Elkin EB, Hudis C, Begg CB, Schrag D. The effect of changes in tumor size on breast carcinoma survival in the U.S.: 1975-1999. Cancer. 2005 Sep 15; 104(6):1149-57. PMID: 16088887.
    Citations: 20     Fields:    Translation:Humans
  183. Schrag D. Communication and coordination: the keys to quality. J Clin Oncol. 2005 Sep 20; 23(27):6452-5. PMID: 16116156.
    Citations: 4     Fields:    Translation:Humans
  184. Schrag D, Chung KY, Flombaum C, Saltz L. Cetuximab therapy and symptomatic hypomagnesemia. J Natl Cancer Inst. 2005 Aug 17; 97(16):1221-4. PMID: 16106027.
    Citations: 43     Fields:    Translation:Humans
  185. Dohan D, Schrag D. Using navigators to improve care of underserved patients: current practices and approaches. Cancer. 2005 Aug 15; 104(4):848-55. PMID: 16010658.
    Citations: 141     Fields:    Translation:Humans
  186. Pham HH, Schrag D, Hargraves JL, Bach PB. Delivery of preventive services to older adults by primary care physicians. JAMA. 2005 Jul 27; 294(4):473-81. PMID: 16046654.
    Citations: 94     Fields:    Translation:Humans
  187. Schrag D. Discussing drug costs with patients. Clin Adv Hematol Oncol. 2005 Jul; 3(7):525-6. PMID: 16167031.
    Citations:    Fields:    Translation:Humans
  188. Temple LK, Bacik J, Savatta SG, Gottesman L, Paty PB, Weiser MR, Guillem JG, Minsky BD, Kalman M, Thaler HT, Schrag D, Wong WD. The development of a validated instrument to evaluate bowel function after sphincter-preserving surgery for rectal cancer. Dis Colon Rectum. 2005 Jul; 48(7):1353-65. PMID: 15868235.
    Citations: 47     Fields:    Translation:Humans
  189. Schrag D, Mitra N, Xu F, Rabbani F, Bach PB, Herr H, Begg CB. Cystectomy for muscle-invasive bladder cancer: patterns and outcomes of care in the Medicare population. Urology. 2005 Jun; 65(6):1118-25. PMID: 15922428.
    Citations: 23     Fields:    Translation:Humans
  190. Basch E, Artz D, Dulko D, Scher K, Sabbatini P, Hensley M, Mitra N, Speakman J, McCabe M, Schrag D. Patient online self-reporting of toxicity symptoms during chemotherapy. J Clin Oncol. 2005 May 20; 23(15):3552-61. PMID: 15908666.
    Citations: 78     Fields:    Translation:Humans
  191. Schrag D, Weiser M, Schattner M, Shia J, Akhurst T. An increasingly common challenge: management of the complete responder with multi-focal metastatic colorectal cancer. J Clin Oncol. 2005 Mar 20; 23(9):1799-802. PMID: 15774773.
    Citations: 2     Fields:    Translation:Humans
  192. Chung KY, Shia J, Kemeny NE, Shah M, Schwartz GK, Tse A, Hamilton A, Pan D, Schrag D, Schwartz L, Klimstra DS, Fridman D, Kelsen DP, Saltz LB. Cetuximab shows activity in colorectal cancer patients with tumors that do not express the epidermal growth factor receptor by immunohistochemistry. J Clin Oncol. 2005 Mar 20; 23(9):1803-10. PMID: 15677699.
    Citations: 240     Fields:    Translation:Humans
  193. Bach PB, Schrag D, Begg CB. Resurrecting treatment histories of dead patients: a study design that should be laid to rest. JAMA. 2004 Dec 08; 292(22):2765-70. PMID: 15585737.
    Citations: 82     Fields:    Translation:Humans
  194. Temple LK, Hsieh L, Wong WD, Saltz L, Schrag D. Use of surgery among elderly patients with stage IV colorectal cancer. J Clin Oncol. 2004 Sep 01; 22(17):3475-84.